TNYA
NASDAQStockTenaya Therapeutics, Inc.
$0.85-0.05 (-5.34%)
52-Week Range
$0.39
$2.10
Key Stats
Market Cap
140.8M
P/E Ratio
—
Dividend Yield
—
Beta
3.23
Volume
2.9M
Avg Volume
7.4M
Performance
1M
+30.62%
3M
+12.03%
6M
-25.59%
YTD
+21.53%
1Y
+27.76%
3Y
-65.98%
5Y
-94.18%
Price Chart
ETF Exposure
TNYA is held by 12 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| IBB | iShares Biotechnology ETF | 0.01% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.01% |
| SBIO.L | Invesco NASDAQ Biotech UCITS ETF | 0.01% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 0.01% |
| VXF | Vanguard Extended Market ETF | 0.00% |
| AVTM | Avantis Total Equity Markets ETF 1 | 0.00% |
| VCNS.TO | Vanguard Conservative ETF Portfolio | 0.00% |
| VEQT.TO | Vanguard All-Equity ETF Portfolio | 0.00% |
| VRIF.TO | Vanguard Retirement Income ETF Portfolio | 0.00% |
| VTI | Vanguard Total Stock Market ETF | 0.00% |
| VUN.TO | Vanguard U.S. Total Market Index ETF | 0.00% |
| VUS.TO | Vanguard U.S. Total Market Index ETF (CAD-hedged) | 0.00% |
About TNYA ETF Exposure
Tenaya Therapeutics, Inc. (TNYA) is held by 12 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 140.8M, TNYA is a widely held institutional stock. The stock currently trades at $0.85. Investors can gain exposure to TNYA through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold TNYA, sorted by portfolio weight.